Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01966003
Title Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Subjects With Advanced Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site Bismarck North Dakota 58501 United States Details
Research Site Fremantle Western Australia 6160 Australia Details
Research Site Veliko Tarnovo Veliko Turnovo 5000 Bulgaria Details
Research Site Ruse 7003 Bulgaria Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field